$5.6 M

REMI Mkt cap, 31-Oct-2017

$678.7 K

Remedent Revenue Q2, 2018
Remedent Gross profit (Q2, 2018)481 K
Remedent Gross profit margin (Q2, 2018), %70.9%
Remedent EBIT (Q2, 2018)-46.2 K
Remedent Cash, 30-Sep-201788.8 K

Remedent Financials

Remedent Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016

Revenue

2.6 m3.6 m2.8 m

Revenue growth, %

39%(23%)

Cost of goods sold

965 k1.3 m817.4 k

Gross profit

1.6 m2.3 m2 m

Gross profit Margin, %

63%65%70%

Sales and marketing expense

682.7 k756.2 k493.8 k

R&D expense

77.5 k61.2 k8.8 k

General and administrative expense

1.4 m1.2 m1.3 m

Operating expense total

2.1 m2 m1.8 m

EBIT

(737.3 k)105.4 k7.2 k

EBIT margin, %

(28%)3%0%

Interest expense

130 k75.1 k63.4 k

Interest income

11.3 k

Income tax expense

30.6 k(22.9 k)

Net Income

524.5 k

Quarterly

USDQ2, 2018

Revenue

678.7 k

Cost of goods sold

197.7 k

Gross profit

481 k

Gross profit Margin, %

71%

Sales and marketing expense

240.1 k

R&D expense

221

General and administrative expense

262.3 k

Operating expense total

527.2 k

Depreciation and amortization

24.7 k

EBIT

(46.2 k)

EBIT margin, %

(7%)

Interest expense

10 k

Remedent Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016

Cash

775.3 k399.1 k94.4 k

Current Assets

3.4 m2.9 m2.9 m

PP&E

489.4 k435.3 k410.9 k

Total Assets

6.2 m5.5 m5.7 m

Current Liabilities

3.8 m3.4 m3.4 m

Long-term debt

273.2 k

Additional Paid-in Capital

24.9 m24.9 m24.9 m

Retained Earnings

(21.1 m)(21 m)(20.8 m)

Total Equity

2.3 m2.1 m2.3 m

Financial Leverage

2.7 x2.6 x2.5 x

Quarterly

USDQ2, 2018

Cash

88.8 k

Inventories

122 k

Current Assets

1.4 m

PP&E

224.5 k

Total Assets

5 m

Accounts Payable

1.2 m

Current Liabilities

1.6 m

Additional Paid-in Capital

24.9 m

Retained Earnings

(19.9 m)

Total Equity

3.3 m

Financial Leverage

1.5 x

Remedent Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016

Net Income

524.5 k

Depreciation and Amortization

240 k254.8 k158.5 k

Cash From Operating Activities

(103.9 k)300.6 k(203.1 k)

Cash From Investing Activities

(81.4 k)(240.5 k)(116.3 k)

Cash From Financing Activities

1.2 m(358.1 k)

Interest Paid

63 k25.1 k13.4 k

Remedent Ratios

USDY, 2017

Revenue/Employee

42.4 k

Financial Leverage

1.5 x
Report incorrect company information